Cargando…
Real-World Clinical and Economic Outcomes Associated with Surgiflo(®) vs Floseal in Cardiovascular Surgeries in the US
BACKGROUND: Topical hemostatic agents are an option for controlling bleeding during cardiovascular surgery. Previous studies comparing topical hemostatic agents in cardiovascular surgery predate the 2012 reformulation of Surgiflo(®), which had been re-engineered to increase paste viscosity and thus...
Autores principales: | Danker, Walter, Aggarwal, Jyoti, Kelkar, Sneha S, Marston, Xiaocong L, Gao, Xin, Johnston, Stephen S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922341/ https://www.ncbi.nlm.nih.gov/pubmed/35299991 http://dx.doi.org/10.2147/CEOR.S338672 |
Ejemplares similares
-
The Use of Surgiflo to Prevent Postoperative Bleeding in Paramedian Forehead Flap
por: Kalandar, Abeer, et al.
Publicado: (2019) -
Floseal-induced small bowel obstruction
por: Ashraf, Hamza, et al.
Publicado: (2022) -
Sclerotherapy using Surgiflo and alcohol: a new alternative for the treatment of aneurysmal bone cysts
por: Ghanem, I., et al.
Publicado: (2017) -
Small Bowel Obstruction After FloSeal Use
por: Clapp, Benjamin, et al.
Publicado: (2011) -
Safety trial of Floseal® haemostatic agent in head and neck surgery
por: Ujam, A, et al.
Publicado: (2012)